• Synthetic biology improves probiotics therapeutic approaches. • Engineering technologies contribute to design probiotics mechanisms of action. • Edition of proteolytic systems induce the generation of specific bioactive peptides. • Engineered probiotics should be evaluated as therapeutic agents in clinical trials. • Therapeutical and technological uses of engineered probiotics are still controversial.